Content
01/05/2024
San Mateo, CA USA
Revagenix
completed undisclosed Series B Round funding. Investors include
Novo Holdings (lead), Tenmile (lead).
About
Revagenix exists to deliver urgently needed anti-infective medicines to patients around the world.
Startup
Sector:
Biotech
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
